Yeah...I view it slightly different than competing share prices. I view it in terms of Market Cap. IMO, that's the key driver here. For example: IMO, Cannabix is no further ahead with FAIMS tech than we are. Yet, Cannabix has a current Market Cap of 133M USD. With today's action, Breathtec currently has a Market Cap of 15M USD. We know the Nash Pharma arm of Breathtec has multiple shots at a multi billion dollar revenue stream and/or inked deal with Big Pharma. So the level of "speculation" that drove Cannabix to nearly 300M USD Market Cap should be a no brainer here in terms of overall value at play. As I have posted before, Breathtec should already be north of $1 and news of an inked deal could put the stock out of reach of would be basement bargain hunters. The mindset here needs to change from thinking pennies to thinking real money related to a Trillion Dollar industry. Last time I checked, medications are right up there with Food and Water in terms of global societal needs not wants. If you go back and read through the news releases at Cannabix, there is absolutely nothing concrete in the news releases that actually warranted a catapult to it's all-time high of nearly $3 USD. As a matter of fact, a month or so prior Cannabix had just completed a Private Placement (dilution), and was still staring (15 months) at the infamous Black|Box. Fast forward >>> Cannabix unleashes news and photos of the Breath Collection Unit (BCU), and the stock remains flat. I mean Pennyland is a fickle crowd to say the least. At some point, Breathtec is going to breakout for good and there will be no stopping it based on nonsense rumors/speculation/negative nancy's/yada yada yada...
Just 1 opinion,
/////AMG
News 
Market Data 
Discover 
AI
